REMEDIA stands as a European Human Exposome research project.
Its unique methodology relies on using atmospheric simulation chambers, integrating a unified clinical data repository and applying advanced machine learning approaches.
The overall objective of the REMEDIA project is to determine how and to what extent the exposome affects the severity and morbidity of Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF) throughout the disease, thus providing key elements to design more tailored prevention and care programs.
Member of the European Human Exposome Network (EHEN)
https://www.humanexposome.eu
This project has received funding from the European Union’s Horizon 2020 Research and Innovation Program under Grant Agreement No 874753.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Several Key Areas Related To The Exposome And Chronic Lung Diseases.
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://h2020-remedia.eu
Remedia - H2020 Questions
Remedia - H2020's website is https://h2020-remedia.eu
Remedia - H2020's LinkedIn profile is https://www.linkedin.com/company/h2020-remedia
Remedia - H2020 has
2 employees.
View email and phone details for 2
employees at Remedia - H2020.
Remedia - H2020's industry is
Research Services
Remedia - H2020's top competitors are
Eximious_h2020,
Hitachi Energy,
Remedia,
Nature Suites Sl,
Unigreenscheme,
Remedia Eurl,
L'auberge Digitale,
Reprotechnique,
Institut Pasteur De La Guadeloupe,
Longitools Project.
Remedia - H2020's categories are Research Services
Remedia - H2020's founding year is 2020
